| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |